"The Balancing Act®" on Lifetime TV Welcomes Incyte Corp. to Show
Pompano Beach, FL (PRBuzz.com) November 16, 2012 -- Producers of the popular morning show The Balancing Act® on Lifetime TV, welcome Incyte Corp. -- producers of Jakafi, the first and only FDA approved agent for MyeloFibrosis -- to the program. The episode will air as part of the "Behind the Mystery: Rare & Genetic Diseases" mini-series.
Jakafi is used for the treatment of intermediate or high risk MyeloFibrosis including Primary MyeloFibrosis, post-polycythemia Vera MyeloFibrosis, and post-essential Thrombocythemia MyeloFibrosis.
A representative of Incyte will be on set to discuss MyeloFibrosis, the signs, symptoms, causes, and diagnosis of the disease as well. The Balancing Act ®will also go behind the scenes for a day in the life of a patient or family member of someone living with MyeloFibrosis.
"We look forward to having Incyte on the show to educate our viewers on MyeloFibrosis and Jakafi. We hope that by pairing up with Incyte we can help viewers who may be experiencing symptoms of this disease but have not been diagnosed yet" says Doug Campbell, Executive VP of Programming for "The Balancing Act®" on Lifetime Television,
Learn more, visit: http://www.jakafi.com and http://www.incyte.comAbout
"The Balancing Act®" on Lifetime Television
"The Balancing Act", America's premier morning show airs weekday mornings on Lifetime Television at 7:00 am (ET/PT). These days, the modern woman is trying to balance it all and the mission at "The Balancing Act" is to bring solutions to our viewers to help them balance life, career, family and most importantly themselves. "The Balancing Act" is a Branded Entertainment show that entertains, educates and engages the viewer.
For more information please contact us at: http://www.TheBalancingAct.com.